Disease severity and response to treatment in Iranian patients with myasthenia gravis.

Farnaz SinaeiFarzad FatehiShahram Oveis GharanSoroush EhsanKoorosh KamaliShahriar Nafissi

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)

The overall outcome was favorable in the majority of patients, despite differences in the disease course and severity. In contrary to the previous reports, anti-MuSK positive patients in our series did not need a more vigorous treatment regimen comparing other serologic subtypes of MG.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
physical activity
emergency department
combination therapy
drug induced